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BACKGROUND & AIMS: Virtual Touch Quantification (VTQ) evaluates liver fibrosis
in patients with chronic liver diseases by measuring shear wave speed in the liver.
We aimed to determine the reliability criteria of VTQ examination.
METHODS: We performed a prospective study of 1094 patients with chronic liver
disease from November 2009 through October 2016 at Angers University Hospital,
and between April 2010 and May 2015 at Bordeaux University Hospital, in France.
All patients underwent liver biopsy analysis (reference standard), and VTQ
examination was made by experienced operators on the same day, or no more than
3 months before or afterward. Advanced liver fibrosis was defined as fibrosis stage
F ≥ 3 according to the scoring system of the Nonalcoholic Steatohepatitis Clinical
Research Network, or fibrosis stage F ≥ 2 according to the Metavir scoring system.
The diagnostic accuracy of VTQ in detection of advanced fibrosis or cirrhosis was
assessed using the area under the receiver operating characteristic (AUROC) and
the rate of correctly classiﬁed patients. Reliability criteria were defined from the
intrinsic characteristics of VTQ examination, which were shown to influence the
diagnostic accuracy.
RESULTS: VTQ identified patients with advanced fibrosis with an AUROC of 0.773 ±
0.014 and correctly classified 72.0% of patients using a diagnostic cut-off value of
1.37 m/s. VTQ identified patients with cirrhosis with an AUROC value of 0.839 ±
0.014 and correctly classified 78.4% of patients using a cut-off value of 1.87 m/s.
The reliability of VTQ decreased with an increasing ratio of interquartile
range/median (IQR/M) in patients with intermediate-high VTQ results. We defined 3
reliability categories for VTQ: unreliable (IQR/M ≥0.35 with VTQ result ≥1.37 m/s),
reliable (IQR/M ≥0.35 with VTQ result <1.37 m/s or IQR/M 0.15-0.34), and very
reliable (IQR/M <0.15). For advanced fibrosis, VTQ correctly classified 57.8% of
patients in the unreliable group, 73.7% of patients in the reliable group, and 80.9%
of patients in the very reliable group (P < .001); for cirrhosis, these values were
50.0%, 83.4%, and 92.6%, respectively (P < .001). Of the VTQ examinations made,
21.4% were unreliable, 55.0% were reliable, and 23.6% were very reliable. The skin-
liver capsule distance was independently associated with an unreliable VTQ
examination, which occurred in 52.7% of patients with a distance of 30 mm or more.
CONCLUSIONS: In a study to determine the reliability of VTQ findings, compared
with results from biopsy analysis, we assigned VTQ examinations to 3 categories
(unreliable, reliable, and very reliable). VTQ examinations with IQR/M ≥0.35 and
≥1.37 m/s had very low diagnostic accuracy. Our reliability criteria for liver fibrosis
assessment with VTQ will help physicians to accurately evaluate the severity of
chronic liver diseases and monitor their progression.
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